Due to the increase in CMA activity in SLE patients, many autoantigens are processed and loaded onto MHC II molecules and presented to autoreactive CD4+ T cells, which promotes autoreactive B cells to proliferate and differentiate into plasma cells. Here, CD4 is linked to systemic lupus erythematosus.